GlassScriptPhysician profile
Kass Sadri
NPI 1013986462
$3,506.07
in general payments reported to CMS, 2019-2025
21 companies · $573 in 2025
The $573 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $755 · 2020: $287 · 2021: $637 · 2022: $667 · 2023: $291 · 2024: $295 · 2025: $573.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,159.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,159.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $661.04 | 2019-2025 | Dupixent |
| Novartis Pharmaceuticals Corporation | $613.81 | 2019-2025 | |
| Abbvie INC. | $490.65 | 2020-2025 | Rinvoq, Skyrizi |
| Amgen INC. | $347.90 | 2019-2025 | Otezla |
| Genzyme Corporation | $331.24 | 2019-2025 | |
| Biofrontera INC. | $197.25 | 2019-2025 | Ameluz, Xepi, Bf-Rhodoled |
| Janssen Biotech, INC. | $176.69 | 2021-2025 | Tremfya, Simponi Aria, Stelara |
| Incyte Corporation | $157.46 | 2022-2025 | Opzelura |
| Sun Pharmaceutical Industries INC. | $127.14 | 2019-2022 | |
| Leo Pharma INC. | $67.46 | 2019-2025 | Anzupgo |
| Dermira, INC. | $52.75 | 2019-2021 | |
| Almirall LLC | $48.18 | 2019-2020 | |
| Lilly USA, LLC | $45.62 | 2020-2022 | |
| Smith+Nephew, INC. | $30.16 | 2023 | Collagenase Santyl |
| Pfizer INC. | $28.34 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $27.22 | 2019 | |
| Kyowa Kirin, INC. | $26.63 | 2022 | |
| Galderma Laboratories, L.P. | $24.75 | 2025 | |
| Celgene Corporation | $20.52 | 2019 | |
| Helsinn Therapeutics (U.S.), INC. | $15.92 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $15.34 | 2025 | Cabtreo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kass Sadri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.